PHILADELPHIA, PA — FMG Leading acquired BroadBranch Advisors on July 31, expanding the Copley Equity Partners-backed healthcare advisory firm’s market intelligence capabilities as executives and investors seek more data-driven support for strategic and investment decisions.
Terms of the transaction were not disclosed.
The deal adds BroadBranch’s competitive and customer research capabilities to FMG Leading’s existing advisory work with healthcare investors and executives. FMG Leading said the combination is intended to give clients a broader view of market conditions alongside organizational and operational data.
The acquisition also extends FMG Leading’s capabilities in the investor-backed healthcare market, where clients are weighing growth strategies against changing competitive conditions and operating pressures.
Matt Brubaker, FMG Leading’s chief executive officer and chairman, said the addition reflects demand for faster translation of market intelligence into business decisions.
“Translating forward-looking intelligence into action faster and more effectively is critical for our clients, especially in the investor-backed healthcare space,” Brubaker stated.
BroadBranch uses an outside-in research approach to gather and test market information for strategic decision-making. Courtney Matson, managing partner at BroadBranch, said the firm’s work is designed to help clients evaluate assumptions and reduce uncertainty around major decisions.
The acquisition combines that research function with FMG Leading’s existing advisory services rather than establishing a separate business line, according to the companies.
FMG Leading is backed by Copley Equity Partners and advises healthcare investors and executives on performance and growth strategy.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.